Deloitte Insights and our research centers deliver proprietary research designed to help organizations turn their aspirations into action.

DELOITTE INSIGHTS

  • Home
  • Spotlight
    • Weekly Global Economic Outlook
    • Top 10 Reading Guide
    • Future of Sports
    • Technology Management
    • Growth & Competitive Advantage
  • Topics
    • Economics
    • Environmental, Social, & Governance
    • Operations
    • Strategy
    • Technology
    • Workforce
    • Industries
  • More
    • About
    • Deloitte Insights Magazine
    • Press Room Podcasts

DELOITTE RESEARCH CENTERS

  • Cross-Industry
    • Home
    • Workforce Trends
    • Enterprise Growth & Innovation
    • Technology & Transformation
    • Environmental & Social Issues
  • Economics
    • Home
    • Consumer Spending
    • Housing
    • Business Investment
    • Globalization & International Trade
    • Fiscal & Monetary Policy
    • Sustainability, Equity & Climate
    • Labor Markets
    • Prices & Inflation
  • Consumer
    • Home
    • Automotive
    • Consumer Products
    • Food
    • Retail, Wholesale & Distribution
    • Hospitality
    • Airlines & Transportation
  • Energy & Industrials
    • Home
    • Aerospace & Defense
    • Chemicals & Specialty Materials
    • Engineering & Construction
    • Mining & Metals
    • Oil & Gas
    • Power & Utilities
    • Renewable Energy
  • Financial Services
    • Home
    • Banking & Capital Markets
    • Commercial Real Estate
    • Insurance
    • Investment Management
    • Cross Financial Services
  • Government & Public Services
    • Home
    • Defense, Security & Justice
    • Government Health
    • State & Local Government
    • Whole of Government
    • Transportation & Infrastructure
    • Human Services
    • Higher Education
  • Life Sciences & Health Care
    • Home
    • Hospitals, Health Systems & Providers​
    • Pharmaceutical Manufacturers​
    • Health Plans & Payers​
    • Medtech & Health Tech Organizations
  • Tech, Media & Telecom
    • Home
    • Technology
    • Media & Entertainment
    • Telecommunications
    • Semiconductor
    • Sports
Deloitte.com
Deloitte Insights logo
  • SPOTLIGHT
    • Weekly Global Economic Outlook
    • Top 10 Reading Guide
    • Future of Sports
    • Technology Management
    • Growth & Competitive Advantage
  • TOPICS
    • Economics
    • Environmental, Social, & Governance
    • Operations
    • Strategy
    • Technology
    • Workforce
    • Industries
  • MORE
    • About
    • Deloitte Insights Magazine
    • Press Room Podcasts
    • Research Centers
  • Welcome!

    For personalized content and settings, go to your My Deloitte Dashboard

    Latest Insights

    Creating opportunity at the intersection of climate disruption and regulatory change

    Article
     • 
    7-min read

    Better questions about generative AI

    Article
     • 
    2-min read

    Recommendations

    Tech Trends 2025

    Article

    TMT Predictions 2025

    Article

    About Deloitte Insights

    About Deloitte Insights

    Deloitte Insights Magazine, issue 33

    Magazine

    Topics for you

    • Business Strategy & Growth
    • Leadership
    • Operations
    • Marketing & Sales
    • Diversity, Equity, & Inclusion
    • Emerging Technologies
    • Economy

    Watch & Listen

    Dbriefs

    Stay informed on the issues impacting your business with Deloitte's live webcast series. Gain valuable insights and practical knowledge from our specialists while earning CPE credits.

    Deloitte Insights Podcasts

    Join host Tanya Ott as she interviews influential voices discussing the business trends and challenges that matter most to your business today. 

    Subscribe

    Deloitte Insights Newsletters

    Looking to stay on top of the latest news and trends? With MyDeloitte you'll never miss out on the information you need to lead. Simply link your email or social profile and select the newsletters and alerts that matter most to you.

Welcome back

To join via SSO please click on the key button below
Still not a member? Join My Deloitte

Clinical leaders' top concerns about reopening

by David Betts, Doug Billings, Natasha Elsner, Hemnabh Varia
  • Save for later
  • Download
  • Share
    • Share on Facebook
    • Share on Twitter
    • Share on Linkedin
    • Share by email
8 minute read 05 June 2020

Clinical leaders' top concerns about reopening The key issues to navigate

8 minute read 06 June 2020
  • David Betts United States
  • Doug Billings United States
  • Natasha Elsner United States
  • Hemnabh Varia India
  • Hemnabh Varia India
  • Save for later
  • Download
  • Share
    • Share on Facebook
    • Share on Twitter
    • Share on Linkedin
    • Share by email
  • Introduction
  • Key findings
  • Conclusions

As COVID-19 cases recede, we explore how health care organizations can ramp up nonurgent procedures once again—the resources they need, the constraints they face, and the possible timelines for things to come back to pre-COVID-19 levels.

Introduction

The COVID-19 pandemic forced many health care providers to stop performing nonurgent procedures in response to state mandates, to ensure the safety of patients and staff, and to deploy resources toward COVID-19 treatment. Much lower volumes of these procedures have led to a considerable drop in revenue. As COVID-19 cases recede, how are hospitals and health systems going about resuming these procedures?

In May 2020, the Deloitte Center for Health Solutions surveyed clinical leaders to understand their concerns, approaches, and steps toward resuming nonurgent procedures.

Methodology

Between May 4 and 15, 2020, the Deloitte Center for Health Solutions conducted a short online survey of 50 clinical leaders, including chief medical officers and service line leaders at provider organizations in the United States. These provider organizations included health systems, free-standing hospitals, academic medical centers, and ambulatory surgery centers with an annual revenue of more than US$500 million in the most recent fiscal year.

 

Key findings

The results suggest that resuming nonurgent procedures will be complex, and clinical leaders are preparing for many uncertainties.

Top concerns include a potential second outbreak, low patient demand, and supplies

Learn more

Explore the health care collection

Visit the Health Forward Blog

Learn about Deloitte's services

Go straight to smart. Get the Deloitte Insights app

While health systems have been at the frontline of caring for patients during the epidemic and have received some financial support from federal legislation, the loss of revenue has been a significant financial challenge for many. Surveyed clinical leaders estimate that the nonurgent procedure volume in April 2020 was just 16% of what it was during the same period last year.

When asked to list their top three concerns about resuming deferred procedures, clinical leaders cite the possibility of an outbreak or a second wave as their number one worry (82%), overshadowing all other concerns. Low patient demand due to safety concerns (54%) and adequate supply of materials, medications, equipment or testing (50%) are a distant second, followed by patients’ ability to pay due to loss of income or insurance (40%).

The possibility of an outbreak or second wave is the number one concern

When it comes to supply chain, the top three concerns include testing capabilities (74%), personal protective equipment or PPE (68%), and the availability of medical and surgical supplies other than PPE (58%). These are all areas in which suppliers can support their customers.

Top concerns about supply chain include inadequate testing capabilities, lack of PPE, and shortage of other medical and surgical supplies

Organizations probably have the least control over the possibility of another outbreak or wave. And a large outbreak can have cascading effects on other important variables: patient demand, availability of testing and supplies, and staffing.

Lingering supply chain issues and the possibility of new outbreaks should compel organizations to rethink how they stock, distribute, forecast, and track supplies by site and service line. Providers may have a newfound desire for upstream visibility into the supply chain, whereas suppliers might want a detailed understanding of downstream utilization. This would call for a much closer coordination among supply chain stakeholders: providers, group purchasing organizations (GPOs), distributors, and medtech companies.

Adequate testing is the key capability organizations are looking for

In response to our question about what capabilities are still lacking, sufficient testing (for the virus and for antibodies) tops the list (figure 3).

While both clinical leaders at organization/system level and leaders at the service line level agree about the lack of testing, their perspectives diverge on three other capabilities:

  • Infection control for operating and procedure rooms: Only 7% of respondents at the service line level feel this capability still needs strengthening, but a much larger share at the organization/system level (47%) feels this way.
  • Understanding readiness and capacity of other community providers (e.g., referring physicians, diagnostic facilities, post-op rehab/follow-up): A much larger percentage of service line leaders (60%) than of organization- or system-level leaders (18%) feel they need to strengthen their organizations’ capability in this area.
  • Capabilities to monitor outbreaks: About 21% of organization-level leaders versus 47% of service line leaders think this is lacking.

These differences may be due to different exposure to what is happening at various levels of the organization or multiple locations, or due to the differences in tactical vs. strategic understanding of what is needed.

Testing is the number one needed capability for resuming deferred procedures

Organizations are trying to mitigate consumer concerns through virtual health practices and communication

To mitigate concerns associated with resuming deferred procedures, clinical leaders say their organizations are putting in place a number of measures (figure 4).

  • Almost everybody (98%) in our survey says their organizations have implemented or plan to implement virtual health practices for some or all nonprocedure visits.

This represents a major shift in practice: the Deloitte 2020 Survey of US Physicians, conducted in January–February 2020 before the COVID-19 pandemic, showed that only 14% of surgical specialists had video visit capabilities and of those who had, a third (34%) were using them. This amounts to just 5% of all surgical specialists having experience with video visits before COVID-19.

  • Nearly all respondents (96%) say their organizations have developed or plan to develop an external communication strategy.

However, measuring consumer sentiment is the least common activity being implemented (36%) according to our survey. Consumer perceptions are likely to affect demand for procedures, which 54% of our respondents noted (figure 1). Individuals who need nonurgent procedures tend to be older than the general population (57 vs. 38 years old, on average) and by some estimates more than three in five have at least one comorbidity,1 putting them at a higher risk of severe illness from COVID-19. These consumers may be especially worried about getting their procedures done while the epidemic continues. Health systems should allay consumers’ concerns by tailoring their communications and showing they are able to minimize the spread of infection through adequate PPE for staff and patients and robust infection control.

We expect consumer attitudes and behaviors to be increasingly important for reopening. Organizations should establish market-sensing capabilities to monitor consumer sentiment by key psychographic segments and geographies. These efforts could focus on consumer confidence (including financial outlook, job security, capacity of the health care system), perceptions of safety, and types of services consumers are cancelling or delaying. They could use multiple data inputs and analytical approaches for the purpose—from survey research to social media to internal information on appointment scheduling and testing.

Survey respondents say they are planning or implementing many steps to prepare for the immediate future

Preplanning and extended hours are the top choices for dealing with potential demand surges

We explored measures being put in place to maximize patient throughput and utilization of operating rooms should there be surges in procedure demand. Surgical preplanning and extending hours of operation are the most common approaches planned or implemented. A quarter of the respondents are not considering approaches to simplify and/or reduce provider preferences, though doing so could help streamline patient scheduling.

Changes to operating hours and scheduling could have implications for external stakeholders such as suppliers, community providers, or medical transport companies, who might need to adjust their practices to help health systems to maximize their capacity.

Even without demand surges, large expenses for treating COVID-19 patients, new and more time-consuming infection control measures, and potential erosion in the payer mix are putting pressure on many organizations to seek efficiencies.

Surveyed clinical leaders expect the return to pre-COVID-19 productivity volumes to take two to six months, with three months being the typical (median) estimate. This relatively optimistic estimate may reflect respondents’ confidence in their organizations’ ability to prepare for reopening.

However, organizations will need to overcome significant operational challenges to reach pre-pandemic productivity. New protocols to minimize infection risk can create inefficiencies and constrain health care systems’ ability to operate at the same capacity as before. Patient scheduling can become more complicated and additional pre-operative testing for the virus and screening patients and staff for symptoms can increase same-day cancellations. Social distancing requirements could mean fewer patients and lower daily caseloads, and additional cleaning and infection controls may slow down room turnover, impacting throughput. It could also mean minimal presence of medical device company representatives or other nonstaff services surgeons rely on to ensure efficiency in their operating rooms.2

Conclusion

Resuming nonurgent procedures may be more complicated and take longer than expected. While everybody is anxious to reopen, the approach should be methodical and allow for contingencies against possible risks to determine when to open, what services to resume, and how to reboot revenue while building resiliency in the system and keeping the patient and the community at the center. Such resiliency will likely require a real-time view of data on consumer sentiment and behavior, the pace and progression of testing, readiness of the clinical and nonclinical workforce, having the operational procedures in place to compartmentalize COVID-19 and non-COVID-19 care, and the financial resiliency to withstand the challenges that organizations may face as they ramp up operations again.

Acknowledgments

Project team: Wendy Gerhardt championed the research concept, ensured timely project execution, and helped edit the paper. Sonal Shah provided support with questionnaire development and interpretation of the findings.

The authors would like to thank Glenn Snyder, Randy Gordon, Kulleni Gebreyes, Claire Boozer Cruse, Jane Makhoul, Sally Bogus, Courtney Burton, Sarah Thomas, Leena Gupta, Pedro Arboleda, Jay Zhu, Laura DeSimio, Ramani Moses, and the many others who contributed their ideas and insights to this project.

Cover image by:

Endnotes
    1. The International Surgical Outcomes Study Group, “Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries,” British Journal of Anaesthesia 117, no. 5 (2016), pp. 605–8; Margaret J. Hall et al., Ambulatory surgery data from hospitals and ambulatory surgery centers: United States, 2010, National Health Statistics Reports, Centers for Disease Control and Prevention, February 28, 2017, p. 5; Erin Duffin, “Median age of the U.S. population 1960–2018,” Statista, August 9, 2019. View in article

    2. American Hospital Association, Association of periOperative Registered Nurses, Advanced Medical Technology Association, Re-entry guidance for health care facilities and medical device representatives, accessed June 3, 2020. View in article

Show moreShow less

Topics in this article

COVID-19 response capabilities for health care organizations: Rapidly combating COVID-19 with resilience

The COVID-19 pandemic has caused health care organizations to adjust to clinical resource and financial challenges that would have previously been unthinkable. Where can your organization focus its response? And what should you do next? Learn how we can help you combat the coronavirus with resilience.

Learn more
Get in touch
Contact
  • David Betts
  • Principal
  • Deloitte Consulting LLP
  • dabetts@deloitte.com
  • +1 412 402 5967

Download Subscribe

Related content

img Trending

The future of virtual health

Article 5 years ago
img Trending

The future of work in health and human services

Article 4 years ago
img Trending

Medicaid in 2040

Article 5 years ago
img Trending

Health tech investment trends: How are investors positioning for the future of health?

Article 5 years ago

Explore more on health care

  • The future of health Collection
  • The economic impact of COVID-19 (novel coronavirus) Article5 years ago
  • Hospital revenue trends Article5 years ago
  • Drug and inpatient spending lines are crossing Article5 years ago
  • Virtual health care Video
David Betts

David Betts

Principal | Deloitte Consulting LLP

David Betts, principal, Deloitte Consulting LLP, is the national leader for Customer Transformation for the health care provider sector. His work focuses on assisting clients to create a more patient-centric, consumer-oriented health care delivery system, bringing innovation and design thinking to our health care clients to improve patient and family experience and engagement.

  • dabetts@deloitte.com
  • +1 412 402 5967
Doug Billings

Doug Billings

Doug leads the MedTech Innovation, Product Development and R&D practice within Deloitte. He has over 30 years of experience in Medical Device innovation, product strategy, product development, operational scale-up and merger integration. He has successfully worked in and with multinational corporations and technology startups to help them successfully conceive, create and commercialize market leading products and solutions. Doug has led several clients through global transformations and scale-up of product development capability across all functions (R&D, Digital Development, Quality, Clinical, Marketing, Regulatory, Manufacturing, Supply Chain and Procurement) resulting in faster and more sustainable realization of growth and profitability objectives. These programs have included the integration of lean, agile, design thinking, concurrent engineering, supplier co-development and other advanced product design, process design and project management methodologies. His experiences includes working across a variety of medical device markets including diabetes and metabolic disease, general surgery, interventional cardiology, interventional oncology, chronic disease management, emergency medicine and interventional neurology. Doug has a degree in Biology from Duke University and an MBA from Ross School of Business at the University of Michigan.

  • dbillings@deloitte.com
Natasha Elsner

Natasha Elsner

Market Insights Manager | Deloitte Services LP

Natasha Elsner is a research manager with the Deloitte Center for Health Solutions. She has spent more than 10 years in market research serving health care clients. With extensive experience in research methodology and data analysis, Elsner conducts cross-sector research at the Center.

  • nelsner@deloitte.com
  • +1 215 282 1087
Hemnabh Varia

Hemnabh Varia

Deputy manager, Deloitte Center for Health Solutions

Hemnabh Varia is a deputy manager with Deloitte Services India Pvt Ltd, affiliated with the Deloitte Center for Health Solutions. He has over 10 years of experience in market research, competitive intelligence, financial analysis, and research report writing. Varia holds a master's degree in business administration from Mumbai University.

  • hvaria@deloitte.com
  • +1 615 209 6741

Share article highlights

See something interesting? Simply select text and choose how to share it:

Email a customized link that shows your highlighted text.
Copy a customized link that shows your highlighted text.
Copy your highlighted text.

Clinical leaders' top concerns about reopening has been saved

Clinical leaders' top concerns about reopening has been removed

An Article Titled Clinical leaders' top concerns about reopening already exists in Saved items

Invalid special characters found 
Forgot password

To stay logged in, change your functional cookie settings.

OR

Social login not available on Microsoft Edge browser at this time.

Connect Accounts

Connect your social accounts

This is the first time you have logged in with a social network.

You have previously logged in with a different account. To link your accounts, please re-authenticate.

Log in with an existing social network:

To connect with your existing account, please enter your password:

OR

Log in with an existing site account:

To connect with your existing account, please enter your password:

Forgot password

Subscribe

to receive more business insights, analysis, and perspectives from Deloitte Insights
✓ Link copied to clipboard

Deloitte Insights and our research centers deliver proprietary research designed to help organizations turn their aspirations into action.

Deloitte Insights

  • Home
  • Topics
  • Industries
  • About Deloitte Insights

DELOITTE RESEARCH CENTERS

  • Cross-Industry
  • Economics
  • Consumer
  • Energy & Industrials
  • Financial Services
  • Government & Public Services
  • Life Sciences & Health Care
  • Tech, Media & Telecom
Deloitte logo

Learn about Deloitte’s offerings, people, and culture as a global provider of audit, assurance, consulting, financial advisory, risk advisory, tax, and related services.

© 2025. See Terms of Use for more information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

  • About Deloitte
  • Terms of Use
  • Privacy
  • Data Privacy Framework
  • Cookies
  • Cookie Settings
  • Legal Information for Job Seekers
  • Labor Condition Applications
  • Do Not Sell My Personal Information